MR flow mapping of dobutamine-induced changes in diastolic heart function

J Magn Reson Imaging. 2004 Feb;19(2):176-81. doi: 10.1002/jmri.10448.

Abstract

Purpose: To evaluate the ability of MR flow mapping to measure changes in left ventricular filling during beta-adrenergic stimulation.

Materials and methods: Mitral flow was measured in 10 healthy volunteers using conventional free breathing fast-field echo (FFE) with a spatial resolution of 2.7 x 2.2 mm and a temporal resolution of 22 msec. The sequence was repeated during dobutamine infusion (20 microg/kg/minute).

Results: Stroke volume increased from a median of 99 mL (range: 68-142 mL) (Note: values as presented are medians and ranges, throughout) to 114 mL (87-180 mL) (P < 0.05). Both early (E) peak filling rate (554 mL/second [433-497 mL] to 651 mL/second [496-1096 mL/second]) (P < 0.05) and atrial (A) peak filling rate (238 mL/second [183-352 mL/second] to 341 mL/second [230-538 mL/second]) (P < 0.05) increased. These changes, together with the increase in E acceleration peak and A deceleration peak, were consistent with facilitated myocardial relaxation.

Conclusion: Conventional free breathing FFE has the ability to measure the effects of beta-adrenergic stimulation on left ventricular filling.

Publication types

  • Evaluation Study

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Adult
  • Cardiac Output / drug effects
  • Coronary Circulation / physiology*
  • Diastole / drug effects
  • Dobutamine / pharmacology*
  • Female
  • Heart Rate / drug effects
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Male
  • Mitral Valve / physiology
  • Reference Values
  • Reproducibility of Results
  • Stroke Volume / drug effects
  • Time Factors
  • Ventricular Function, Left / drug effects*

Substances

  • Adrenergic beta-Agonists
  • Dobutamine